[Analysis of overactive bladder and urinary incontinence in males in the age range between 50 and 65 years. EPICC study].
BACKGROUND
The Overactive Bladder syndrome (OAB) and Urinary Incontinence (UI) result in an important personal and economic impact. This work concentrates on the detailed analysis of OAB and UI (derived symptoms and tendencies in medical consultation and resource consumption), in a sample of working men aged 50-65.


METHODS
This study is within the framework of the EPICC study of the Spanish Association of Urology (epidemiologic, observational, multicentric, national study) and concentrates on the detailed analysis of the characteristics of the sample of working men aged 50-65 (N<or=1071) and of the subgroup of individuals with VH and/or IU (N<or=55).


RESULTS
0.56% of the subjects presented UI, 3.55% OAB, 1.03% presented both pathologies. Taking into account those individuals with UI and/or OAB, 45.45% had problems to retain urine, and 16.36% suffered leakage daily; 45.45% suffered uncontrollable urge to urinate daily; 23.64% had never sought medical advice, 65.45% had visited an urologist, 14.55% would like to visit an specialist in incontinence; 40% had received treatment, from which 81.82 had received pharmacologic treatment.


CONCLUSIONS
In this study, specific data about VH and IU in the reported sample are presented, including those referring to the magnitude of these conditions and use of sanitary resources in subjects with UI and/or OAB, aiming at contributing to a better diagnose and handling of patients and resources.
Martínez-Agulló
E
E
Servicio de Urología, Hospital Universitario La Fe, Valencia, España.
Ruíz Cerda
J L
JL
Arlandis Guzmán
S
S
Rebollo
P
P
Pérez
M
M
Chaves
J
J
D000368:Aged; D006295:Health Resources / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000628:therapy*; D014549:Urinary Incontinence / Q000175:diagnosis* / Q000628:therapy*